BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27476166)

  • 1. Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
    Luan JJ; Xing GQ
    J Nephrol; 2017 Feb; 30(1):63-71. PubMed ID: 27476166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
    Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
    Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
    Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
    Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.
    Hurtado PR; Jeffs L; Nitschke J; Patel M; Sarvestani G; Cassidy J; Hissaria P; Gillis D; Peh CA
    BMC Immunol; 2008 Jul; 9():34. PubMed ID: 18625057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of astaxanthin on ANCA-associated vasculitis.
    Sun RL; Shang JC; Han RH; Xing GQ
    Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
    van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO
    Front Immunol; 2020; 11():566732. PubMed ID: 33384685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
    Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
    Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
    Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
    [No Abstract]   [Full Text] [Related]  

  • 11. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
    Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
    Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
    Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
    APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired HVJ-stimulated Interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection.
    Uno K; Muso E; Ito-Ihara T; Endo T; Yasuda Y; Yagi K; Suzuki K
    Cytokine; 2020 Dec; 136():155221. PubMed ID: 32828064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
    de Souza A; Westra J; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Kallenberg CG
    Arthritis Res Ther; 2013; 15(5):R104. PubMed ID: 24007972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
    Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum peptidylarginine deiminase type 4 in ANCA-associated vasculitis.
    Wang ZL; Shang JC; Li CM; Li M; Xing GQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):200-6. PubMed ID: 24743806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.
    Jeffs LS; Peh CA; Nelson A; Tan PG; Davey E; Chappell K; Perkins GB; Hurtado PR
    Immunol Res; 2019 Oct; 67(4-5):325-336. PubMed ID: 31372816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis.
    Elmér E; Smargianaki S; Pettersson Å; Skattum L; Ohlsson S; Hellmark T; Johansson ÅCM
    J Immunol Res; 2020; 2020():8209737. PubMed ID: 33313327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV).
    Schneeweis C; Rafalowicz M; Feist E; Buttgereit F; Rudolph PE; Burmester GR; Egerer K
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):62-6. PubMed ID: 20412705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.